Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The over-arching goal of the New IDEAS study is to evaluate the utility of beta-amyloid PET to "exclude Alzheimer's disease (AD) in narrowly defined and clinically difficult differential diagnoses" in a broad and diverse population of Medicare beneficiaries with cognitive impairment.
Location: Mills (Peninsula)
Location: REDI (East Bay) Contact: Yomi Kapasi, CRC
Location: PAMF (Peninsula/Sout Bay/Santa Cruz)
Location: SIMR (Sacramento/Valley Area)
Principal Investigator
David Eric Collins, MD, Brajesh Agrawal, MD
Co-Investigator(s)
Minal Bhanushali, MD, PAMFRI Medical Director
Funder
American College of Radiology
Related Studies
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD